GLP-1 in higher amounts also interacts with the parts ofthe brain that reduce appetite and signal a feeling of fullness
More realistic estimate: late 2027, with the drug available at pharmacies in early 2028
Patients with a personal history of medullary thyroid carcinoma (MTC) should never receive semaglutide , regardless of treatment status or time since diagnosis
doi: 10.1056/NEJMoa1607141 29 PratleyREArodaVRLingvayILdemannJAndreassenCNavarriaAet al
This reduces hunger, slows digestion, and helps the body manage energy intake more efficiently, which is why semaglutide plasma donation considerations focus on overall stability rather than medication alone
That said, semaglutide was initially developed for the treatment of type 2 diabetes, which is a chronic condition that may require taking medication for life